ArticleIndian journal of surgical oncology2025
A Rare Case of Adult Embryonal Rhabdomyosarcoma of the Uterus in a Postmenopausal Woman.
Article in Indian journal of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rhabdomyosarcoma is a malignant soft tissue tumor arising from undifferentiated myogenic progenitor cells, predominantly occurring in children. Here, we report a peculiar case of adult rhabdomyosarcoma of the uterus in a postmenopausal lady, who presented with heaviness in the lower abdomen and a large abdominopelvic mass. In this article, we discuss the difficulty in diagnosing such cases and the crucial role of immunohistochemistry. This case report highlights the importance of considering rhabdomyosarcoma as a differential diagnosis in atypical soft tissue tumors, especially in postmenopausal women. Rhabdomyosarcoma of the uterus in adults being very rare, there is limited data on the appropriate management guidelines. Our patient received multimodality treatment with surgery followed by palliative chemotherapy and radiotherapy for recurrence of the disease. As rhabdomyosarcoma is very aggressive, prognosis is often poor. Hence, early diagnosis and prompt initiation of multidisciplinary treatment offer the best chance of survival for these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.